Cargando…
Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
Over the past century, solid organ transplantation has been improved both at a surgical and postoperative level. However, despite the improvement in efficiency, safety, and survival, we are still far from obtaining full acceptance of all kinds of allograft in the absence of concomitant treatments. T...
Autores principales: | Marín, Eros, Cuturi, Maria Cristina, Moreau, Aurélie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827529/ https://www.ncbi.nlm.nih.gov/pubmed/29520275 http://dx.doi.org/10.3389/fimmu.2018.00274 |
Ejemplares similares
-
Translating tolerogenic therapies to the clinic – where do we stand?
por: Issa, Fadi, et al.
Publicado: (2012) -
Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
por: Moreau, Aurélie, et al.
Publicado: (2012) -
Translating Tolerogenic Therapies to the Clinic – Where Do We Stand and What are the Barriers?
por: Cobbold, Stephen P., et al.
Publicado: (2012) -
Cell therapy using tolerogenic dendritic cells in transplantation
por: Moreau, Aurélie, et al.
Publicado: (2012) -
Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
por: Zhuang, Quan, et al.
Publicado: (2020)